Causal bacterium | Tissue/Organ | Suggested candidate gene/pathway or major conclusion |
---|---|---|
S. Typhimurium | * | HP, NCF2, PGD[3] |
 | intestine (jejunum, ileum and colon) | TLR-2, NOD-1, NOD-2, PBD-2, NF-κB1, caspase-1 Regional differences in gene expression profiles and inflammatory response to S. typhimurium infection along the porcine intestinal gut exist [64] |
 | macrophage | Enhanced uptake of S. typhimurium in macrophages is associated with ERK1/2 activation [63] |
 | intestinal epithelial cell | |
 | * | CCT7[69] |
 | in vivo gut loop model | NOD-2, TLR-2, TLR-4, TLR5, CCR9, CCRL1[65] |
 | mesenteric lymph node | T helper 1, innate/inflammatory, and antigen-processing pathways are induced; apoptosis and antigen presentation/dendritic cell function pathways are down-regulated; NF-kappaB suppression in antigen-presenting cells may be the mechanism for S. Typhimurium evasion [62] |
 | mesenteric lymph node | CD47, CXCL10, SCARB2, INDO, IRF1, SOCS1, STAT1, SLC11A1[47] |
S. Choleraesuis | * | 14 different chromosomal regions in the porcine genome are found to be significantly associated with susceptibility [24] |
 | mesenteric lymph node | Th1, innate immune/inflammation response, apoptosis pathway, and strong NF-kappaB-dependent response are induced [35] |
 | mesenteric lymph node | ARPC2, CCT7, HSPH1, LCP1, PTMA, SDCBP, VCP, INDO, SOCS1, STAT1, SLC11A1[48] |
 | lung | TGM1, TGM3, GBP1, GBP2, C1S, C1R, MHC2TA, PSMB8, TAP1, TAP2 |
 |  | Apoptotic pathways, Th1 immune response, and interferon gamma (IFNG) signal are observed [2, 66] |
E. coli | * | HEG1, ITGB5[70]; MUC4[71, 72]; FUT1[73, 74]; B3GNT5[75, 76]; MUC20[77]; MUC13[18]; TFRC[75, 78]; B3GALT3, B4GALT4[75] |
 | duodenum | Genes related to the Glycan Biosynthesis and Metabolism are observed [79] |
 | Jejunal mucosa | THO complex 4 [80] |
A. pleuropneumoniae | lung | MMP-9, MMP-12[81] |
 | liver | liver plays an important role in initiating and orchestrating the innate immune response to A. pleuropneumoniae infection [82] |
 | * | TF[83] |
 | peripheral blood leukocytes | OAS1, CD97, S100A8, TGM3[84] |
 | lung, liver, tracheobronchial lymph node | 357, 713, and 130 differentially expressed genes are observed in lung, liver, and tracheobronchial lymph node, respectively (For more details see [85]) |
H. parasuis | porcine alveolar macrophage | S100A4, S100A6, coronin1a, etc. Cell adhesion molecules, cytokine-cytokine receptor interaction, complement and coagulation cascades, toll-like receptor signaling pathway, and MAPK signaling pathway are significantly effected [86] |
 | * | FUT1[87] |
 | lung | Candidate genes and pathways for disease resistance or susceptibility phenotypes are identified (For more details see [88]) |
 | * | CAV1[89] |
 | spleen | |
L. intracellularis | intestinal tissue | IGFBP-3[90] |
K. pneumoniae | N/A | N/A |
Y. pseudotuberculosis | N/A | N/A |
Y. enterocolitica | N/A | N/A |
C. coli | N/A | N/A |